Zhang, Wei <br/><br/>
Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway.  [electronic resource] 

 -  Fundamental & clinical pharmacology  Dec 2016 
 - 596-606 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1472-8206 
<br/><br/><label>Standard No.: </label>10.1111/fcp.12225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Alkaline Phosphatase--metabolism<br/>Bone Morphogenetic Proteins--metabolism<br/>Bone and Bones--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Flavonoids--physiology<br/>Flavonols--pharmacology<br/>Genetic Markers<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Mesenchymal Stem Cells--drug effects<br/>Osteoblasts--drug effects<br/>Osteogenesis--drug effects<br/>Wnt Signaling Pathway--drug effects<br/>beta Catenin--metabolism